Advertisement

Atopic Dermatitis Pertaining to Adolescents

  • Rekha Raveendran
  • Benjamin T. Prince
Chapter

Abstract

Atopic dermatitis (AD) is a chronic, relapsing, and pruritic disease that classically develops in early childhood and can persist into adulthood. There appear to be many contributing factors in the development of this disease including both genetic and environmental interactions, which ultimately lead to impaired epidermal barrier function and immune dysregulation. AD has a variable presentation depending on age, and the diagnosis is based on clinical history and diagnostic characteristics. As AD patients transition to adulthood, they are faced with a unique set of problems that need to be considered. In this chapter we will discuss management of AD in the adolescent and review specific pitfalls that may occur.

Keywords

Atopic dermatitis Eczema Pruritus Adolescence Topical corticosteroids Topical calcineurin inhibitors Antihistamines Immunosuppressants Dupilumab 

References

  1. 1.
    Kim JP, Chao LX, Simpson EL, Silverberg JI. Persistence of atopic dermatitis (AD): a systematic review and meta-analysis. J Am Acad Dermatol. 2016;75(4):681–687.e11.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Brenninkmeijer EEA, Legierse CM, Sillevis Smitt JH, Last BF, Grootenhuis MA, Bos JD. The course of life of patients with childhood atopic dermatitis. Pediatr Dermatol. 2009;26(1):14–22.CrossRefPubMedGoogle Scholar
  3. 3.
    Ricci G, Bellini F, Dondi A, Patrizi A, Pession A. Atopic dermatitis in adolescence. Dermatol Reports. 2012;4(1):e1.CrossRefPubMedGoogle Scholar
  4. 4.
    Eichenfield LF, Tom WL, Chamlin SL, Feldman SR, Hanifin JM, Simpson EL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338–51.CrossRefPubMedGoogle Scholar
  5. 5.
    Bieber T. How to define atopic dermatitis? Dermatol Clin. 2017;35(3):275–81.CrossRefPubMedGoogle Scholar
  6. 6.
    Siegfried EC, Hebert AA. Diagnosis of atopic dermatitis: mimics, overlaps, and complications. J Clin Med. 2015;4(5):884–917.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    van Zuuren EJ, Fedorowicz Z, Christensen R, Lavrijsen A, Arents BW. Emollients and moisturisers for eczema. Cochrane Database Syst Rev. 2017;2:CD012119.PubMedGoogle Scholar
  8. 8.
    Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116–32.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Nicol NH, Boguniewicz M, Strand M, Klinnert MD. Wet wrap therapy in children with moderate to severe atopic dermatitis in a multidisciplinary treatment program. J Allergy Clin Immunol Pract. 2014;2(4):400–6.CrossRefPubMedGoogle Scholar
  10. 10.
    Schneider L, Tilles S, Lio P, Boguniewicz M, Beck L, LeBovidge J, et al. Atopic dermatitis: a practice parameter update 2012. J Allergy Clin Immunol. 2013;131(2):295–9.e1–27.CrossRefPubMedGoogle Scholar
  11. 11.
    Crall CS, Rork JF, Delano S, Huang JT. Phototherapy in children: considerations and indications. Clin Dermatol. 2016;34(5):633–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Sidbury R, Davis DM, Cohen DE, Cordoro KM, Berger TG, Bergman JN, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71:327–49.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Sokolova A, Smith SD. Factors contributing to poor treatment outcomes in childhood atopic dermatitis. Australas J Dermatol. 2015;56(4):252–7.CrossRefPubMedGoogle Scholar
  14. 14.
    Chong M, Fonacier L. Treatment of eczema: corticosteroids and beyond. Clin Rev Allergy Immunol. 2016;51(3):249–62.CrossRefPubMedGoogle Scholar
  15. 15.
    Ou L-S, Goleva E, Hall C, Leung DYM. T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J Allergy Clin Immunol. 2004;113(4):756–63.CrossRefPubMedGoogle Scholar
  16. 16.
    Friedman B-C, Goldman RD. Anti-staphylococcal treatment in dermatitis. Can Fam Physician. 2011;57(6):669–71.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Buddenkotte J, Steinhoff M. Pathophysiology and therapy of pruritus in allergic and atopic diseases. Allergy. 2010;65(7):805–21.CrossRefPubMedGoogle Scholar
  18. 18.
    Fishbein AB, Vitaterna O, Haugh IM, Bavishi AA, Zee PC, Turek FW, et al. Nocturnal eczema: review of sleep and circadian rhythms in children with atopic dermatitis and future research directions. J Allergy Clin Immunol. 2015;136(5):1170–7.CrossRefPubMedGoogle Scholar
  19. 19.
    Blauvelt A, de Bruin-Weller M, Gooderham M, Cather JC, Weisman J, Pariser D, et al. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. Lancet. 2017;389(10086):2287–303.CrossRefPubMedGoogle Scholar
  20. 20.
    Pittet I, Berchtold A, Akre C, Michaud PA, Suris JC. Are adolescents with chronic conditions particularly at risk for bullying? Arch Dis Child. 2010;95(9):711–6.CrossRefPubMedGoogle Scholar
  21. 21.
    Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;11:CD000011.Google Scholar
  22. 22.
    Sidbury R, Tom WL, Bergman JN, Cooper KD, Silverman RA, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 4. Prevention of disease flares and use of adjunctive therapies and approaches. J Am Acad Dermatol. 2014;71(6):1218–33.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Taddeo D, Egedy M, Frappier J-Y. Adherence to treatment in adolescents. Paediatr Child Health. 2008;13(1):19–24.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Halvorsen JA, Lien L, Dalgard F, Bjertness E, Stern RS. Suicidal ideation, mental health problems, and social function in adolescents with eczema: a population-based study. J Invest Dermatol. 2014;134(7):1847–54.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Allergy and Immunology, Department of OtolaryngologyThe Ohio State University Wexner Medical CenterColumbusUSA
  2. 2.Division of Allergy and ImmunologyNationwide Children’s HospitalColumbusUSA

Personalised recommendations